HEIQ MEDICA SL
Company details
- No Activa NIF/CIF: B93748952
-
-
-
-
Address: CTRA DE MARBELLA A-355 Km 19 (COIN) See in map
-
-
Featured products:
More information on HEIQ MEDICA SL
-
21/10/2024 | BORME act no.: 448590 | Register: MÁLAGACeses/Dimisiones
-
21/10/2024 | BORME act no.: 448590 | Register: MÁLAGASituación concursal
-
21/10/2024 | BORME act no.: 448590 | Register: MÁLAGASituación concursal
-
21/10/2024 | BORME act no.: 448590 | Register: MÁLAGASituación concursal
-
21/10/2024 | BORME act no.: 448590 | Register: MÁLAGASituación concursal
-
21/10/2024 | BORME act no.: 448590 | Register: MÁLAGADisolución
-
04/02/2021 | BORME act no.: 55703 | Register: MÁLAGANombramientos
-
24/11/2020 | BORME act no.: 410291 | Register: MÁLAGAModificaciones estatutarias
-
24/11/2020 | BORME act no.: 410291 | Register: MÁLAGACambio de denominación social
-
28/07/2020 | BORME act no.: 244229 | Register: MÁLAGAAmpliación de capital
Other information
The CIF of HEIQ MEDICA SL is B93748952, and its status in the business field is dissolved. The company's economic activity is classified under CNAE -. Additionally, its SIC code - also identifies it. HEIQ MEDICA SL has a team of Between 1 and 9 employees and records an annual turnover of less than 2 million euros. The company is registered in the Mercantile Registry of Málaga, with a total of 3 executive positions. The last announcement in Borme was published on 21/10/2024, and its last submission of ordinary annual accounts corresponds to the year 2022. To obtain contact information for HEIQ MEDICA SL, such as phone number, address, or website, you can visit the Company Data module. If you wish to obtain more information about HEIQ MEDICA SL, you can review some of our available financial reports, the company's Annual Accounts, or check its default incidents in the RAI delinquency file. The financial, business, and legal information provided for HEIQ MEDICA SL comes from official sources and is up to date as of today.
Do you want to know more about HEIQ MEDICA SL??
Find out more about this company by consulting these reports: